FreeTender
Accepting bidsgrantUnited States

RFPs: Phased Large Awards for Comparative Effectiveness Research (US)

Published
20 Nov 2026
Closes
6 Jan 2027, 23:59 UTC
Reference
rfps-phased-large-awards-for-comparative-effectiveness-research-us
Location
United States
Sector
Healthcare & Pharma

At a glance

A buyer in United States has published a funding call in healthcare & pharma: “RFPs: Phased Large Awards for Comparative Effectiveness Research (US)”. Submissions close on 6 January 2027, 47 days from today. Quote reference rfps-phased-large-awards-for-comparative-effectiveness-research-us in any correspondence with the buyer. There are 360 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through fundsforNGOs — grants & funding calls, not through FreeTender.

Details

The Patient-Centered Outcomes Research Institute (PCORI) invites applications for the Phased Large Awards for Comparative Effectiveness Research (PLACER) for Cycle 1, 2027. This funding opportunity supports large-scale, patient-centered comparative clinical effectiveness research projects that address critical healthcare decisions. The application deadline is January 06, 2027. Opportunity at a Glance

- Provider: Patient-Centered Outcomes Research Institute (PCORI)

- Opportunity Type: Research Funding

- Funding Available: Up to $22 million in direct costs per project

- Eligible Applicants: Researchers conducting patient-centered comparative clinical effectiveness research

- Eligible Countries: United States

- Application Deadline: January 06, 2027, 5 pm (ET)

- Project Duration: Up to 6.5 years (Feasibility phase: 1.5 years; Full-scale phase: 5 years)

About the Opportunity

PCORI’s Phased Large Awards for Comparative Effectiveness Research aim to generate evidence that helps patients, families, and healthcare providers make informed health decisions. The program supports projects that compare the clinical effectiveness of different interventions to address decisional dilemmas in health and healthcare. Funding and Benefits

- Feasibility Phase: Up to $2 million in direct costs, lasting up to 18 months.

- Full-Scale Phase: Up to $20 million in direct costs, lasting up to five years.

- Total Funding Pool: $120 million

- Funding covers study design, patient and stakeholder engagement, and intervention testing. Who Is Eligible? - Researchers proposing individual-level or cluster randomized controlled trials. - Projects must be of significant scale and scope. - Must include shared trial leadership with a data coordinating center. Eligible Activities or Priority Areas - Comparative effectiveness research comparing interventions with robust evidence of efficacy. - Projects aligned with PCORI’s Research Project Agenda Topic Themes. - Supported activities include study refinement, infrastructure establishment, and stakeholder engagement. Why This Opportunity Matters The PLACER funding supports research that fills evidence gaps in healthcare, addressing critical decisions faced by patients and healthcare providers. By fostering comparative effectiveness research, PCORI contributes to improved health outcomes and patient-centered care. How to Apply - Read Full PLACER PFA and FAQs: Understand requirements and expectations. - Submit a Letter of Intent (LOI): By 6 January 2027, 5 pm (ET) via PCORI Connect.

- Application Submission: Upon invitation, submit through PCORI Connect.

Application Tips or Common Mistakes - Ensure the proposed study aligns with PCORI’s strategic priorities. - Include detailed engagement plans for patients and stakeholders. - Utilize PCORI Connect resources for a streamlined submission process. Frequently Asked Questions What is the total funding available for this opportunity? Up to $120 million is available for this funding cycle. What are the phases of the project?

There are two phases: a feasibility phase (up to 18 months) and a full-scale phase (up to five years).

Who can apply for this funding? Researchers in the U.S. conducting patient-centered comparative effectiveness research. What is the deadline for the Letter of Intent? The deadline for submitting the LOI is 6 January 2027, 5 pm (ET). How can I submit my application? Applications are submitted through PCORI Connect, following LOI acceptance and invitation. Next Steps Eligible applicants should review the official guidelines and begin preparing their LOI by the specified deadline. Visit the PCORI website for more information and application resources.

Context for bidders

There are 360 open Healthcare & Pharma tenders in United States. This one closes in 47 days.

Explore United States

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →